Arbutus Biopharma Corp Net Income per Employee (ABUS), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Arbutus Biopharma Corp  (NASDAQ: ABUS)
 

Arbutus Biopharma Net Income per Employee

ABUS's Quarterly Results, Trends, Rankings, Statistics
Arbutus Biopharma's Income per employee fell in the second quarter 2026 on a trailing twelve month basis to $ 8,055,474, but the productivity of Arbutus Biopharma's 19 employees remained above the company average.
The Healthcare sector has seen employees of 5 other companies achieving higher income per employee. While Arbutus Biopharma's total ranking has deteriorated compared to the previous quarter from 29 to 33.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABUS Net Income per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 8,055,474 8,458,947 -1,763,211 -5,905,105 -6,535,368
ABUS's Total Ranking # 33 # 29 # 3837 # 3517 #
Seq. Net Income Change - - - - -

ABUS Company Profile >> Back to ABUS Efficiency Comparisons >> Compare ABUS Net Income per Employee to its Competitors

ABUS Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 6
Overall Market # 33

Net Income per Employee Statistics
High Average Low
$ 8,458,947 $ -4,721,084 $ -20,364,053
(Mar 31 2026)   (Mar 31 2017)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Oramed Pharmaceuticals Inc  13,451,076.92 $ 174.864  Million 13 
Vertex Pharmaceuticals Inc  10,877,037.04 $ 4,405.200  Million 405 
Vor Biopharma Inc   8,260,250.00 $ 627.779  Million 76 
Arbutus Biopharma Corp  8,055,473.68 $ 153.054  Million 19 
Oncotelic Therapeutics Inc   6,507,380.66 $ 247.280  Million 38 
Ligand Pharmaceuticals Incorporated  4,196,170.21 $ 197.220  Million 47 


Date modified: 2026-09-03T23:29:01+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.